Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Alx Oncology Holdings Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 108 | 1 | 96 | −11 |
| Shares | 36.3M | 24.5K | 36.8M | +525.4K (+1.4%) |
| Value | $780.0M | $527.0K | $621.9M | −$157.5M (−20.2%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Alx Oncology Holdings Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Samsara BioCapital, LLC | 262,786 | $4.44M | 1.12% |
| Federated Hermes, Inc. | 54,107 | $914.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 32,900 | $556.0K | 0.01% |
| IndexIQ Advisors LLC | 22,127 | $374.0K | 0.01% |
| Cim Investment Mangement Inc | 10,706 | $181.0K | 0.06% |
| Barclays PLC | 4,707 | $80.0K | 0.00% |
| Amalgamated Bank | 2,898 | $49.0K | 0.00% |
| Amalgamated Financial Corp. | 2,898 | $49.0K | 0.00% |
| Lindbrook Capital, LLC | 134 | $2.00K | 0.00% |
| Allworth Financial LP | 10 | $0 | 0.00% |
Sold out (21)
Institutions that held Alx Oncology Holdings Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Janus Henderson Group PLC | 918,908 | $19.8M |
| Marshall Wace, LLP | 106,875 | $2.29M |
| Walleye Capital LLC | 58,744 | $1.26M |
| Trexquant Investment LP | 28,678 | $616.0K |
| Nomura Holdings Inc | 26,424 | $570.0K |
| Gsa Capital Partners LLP | 24,203 | $520.0K |
| First Trust Advisors LP | 21,777 | $468.0K |
| Twinbeech Capital LP | 21,500 | $462.0K |
| Qube Research & Technologies Ltd | 19,190 | $412.0K |
| Atom Investors LP | 15,477 | $333.0K |
| PDT Partners, LLC | 15,154 | $326.0K |
| Teachers Retirement System of the State of Kentucky | 11,471 | $247.0K |
| Engineers Gate Manager LP | 10,700 | $230.0K |
| Manufacturers Life Insurance Company, The | 9,857 | $212.0K |
| ProShare Advisors LLC | 9,579 | $205.0K |
| Erste Asset Management GmbH | 9,200 | $201.8K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 611 | $13.0K |
| TCI Wealth Advisors, Inc. | 131 | $3.00K |
| Andrew Hill Investment Advisors, Inc. | 100 | $2.00K |
| Captrust Financial Advisors | 13 | $0 |
| Covestor Ltd | 8 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Alx Oncology Holdings Inc at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| AlphaCentric Advisors LLC | 24,500 | $527.0K |